Background Important insights into the early pathogenesis of Alzheimer's disease can be
provided by studies of autosomal dominant Alzheimer's disease and Down syndrome. However…

Background The Down syndrome population has been disproportionately affected by Coronavirus
2019 (COVID-19) in terms of experiencing severe illness and death. Societal efforts to …

Introduction Adults with Down syndrome (DS) are at high risk for early onset Alzheimer's
disease (AD), characterized by a progressive decline in multiple cognitive domains including …

Background In people with genetic forms of Alzheimer's disease, such as in Down syndrome
and autosomal-dominant Alzheimer's disease, pathological changes specific to Alzheimer's …

Background The accuracy of the National Task Group‐Early Detection Screen for Dementia
(NTG‐EDSD) was evaluated in a sample of 185 adults with Down syndrome (DS), …

Introduction Virtually all adults with Down syndrome (DS) develop Alzheimer's disease (AD)‐associated
neuropathology by the age of 40, with risk for dementia increasing from the early …

Introduction The development of valid methods to diagnose prodromal Alzheimer's disease (AD)
in adults with Down syndrome (DS) is one of the many goals of the Alzheimer's …

Accurate identification of the prodromal stage of Alzheimer’s disease (AD), known as mild
cognitive impairment (MCI), in adults with Down syndrome (MCI-DS) has been challenging …

Introduction Down syndrome (DS) is associated with a higher risk of dementia. We hypothesize
that amyloid beta (Aβ) in specific brain regions differentiates mild cognitive impairment in …

Self‐concept is a critical indicator of quality of life but few studies have examined this subject
in children with Down syndrome (DS). In this study, we propose a novel methodology to …